ISIS Pharmaceuticals (ISIS) Bullish Stance Reiterated at BMO Capital Amid ISIS-SMNRX Data Jun 11, 2015 08:16AM
BMO Keeps ISIS Pharma (ISIS) at 'Outperform' Following ISIS-BIIB4Rx Milestone Feb 5, 2015 12:40PM
Regulus Therapeutics (RGLS) 5.29M Offering Prices at $17/Share Oct 29, 2014 06:50AM
Streetinsider.com's Hot Lunchtime Reads 8/28: (TKMR) (MSFT) (ISIS) (WDAY) Aug 28, 2014 12:12PM
ISIS Pharmaceuticals (ISIS) Bullish Stance Reiterated at BMO Capital Amid FCS Phase 3 Initiation Aug 28, 2014 11:33AM


May 8, 2014 06:34AM ISIS Pharmaceuticals (ISIS) Bullish Stance Reiterated at BMO Capital Post Q1
Mar 31, 2014 12:11PM Streetinsider.com's Hot Lunchtime Reads 03/31: (ISIS) (IMAX) (TSLA) (GILD)
Mar 31, 2014 11:32AM ISIS Pharmaceuticals (ISIS) ApoCIII Continues to Show Unprecedented Lipid Benefits - BMO Capital
Mar 27, 2014 06:45AM Activity of ISIS 560131/AZD5321 (ISIS) 'Incredibly Exciting' - BMO Capital
Mar 10, 2014 02:52PM Competitor Data Positive for ISIS Pharmaceuticals (ISIS), BMO Capital Says
Jun 24, 2013 10:56AM ISIS Pharmaceuticals (ISIS) Results Called 'Stunning'
Oct 4, 2012 04:09PM Regulus Therapeutics (RGLS) IPO Closes 5% Higher
Sep 7, 2011 05:54PM BMO Starts Biotech Stocks: AMGN, HGSI, REGN, CELG at Outperform, AMLN, GILD, ARNA at Market Perform, BIIB at Underperform